Gilead Sciences (GILD) Long-Term Debt Issuances (2010 - 2024)

Gilead Sciences has reported Long-Term Debt Issuances for 10 years, with the latest figure at $3.5 billion in Q4 2024.

• For the quarter ending Q4 2024, Long-Term Debt Issuances rose 346300.0% year-over-year to $3.5 billion; the trailing twelve-month figure through Dec 2024 stood at $3.5 billion (up 247.89% YoY), and the FY2024 full-year result was $3.5 billion, up 74.95% from the prior year.
• Long-Term Debt Issuances for Q4 2024 stood at $3.5 billion, up from $1.0 million in the prior quarter.
• The five-year high for Long-Term Debt Issuances was $3.5 billion in Q4 2024, with the low at $1.0 million in Q4 2023.
• Historically, Long-Term Debt Issuances has averaged $1.5 billion across 3 years, with a median of $995.0 million in 2020.
• The largest YoY upside for Long-Term Debt Issuances was 346300.0% in 2024 against a maximum downside of 346300.0% in 2024.
• Gilead Sciences' Long-Term Debt Issuances stood at $995.0 million in 2020, then tumbled by 99.9% to $1.0 million in 2023, then soared by 346300.0% to $3.5 billion in 2024.
• The last three Long-Term Debt Issuances figures came in at $3.5 billion (Q4 2024), $1.0 million (Q4 2023), and $995.0 million (Q4 2020), per Business Quant data.